Bluefin Capital Management’s Eli Lilly LLY Stock Holding History

Bluefin Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$463K	Buy	+386	New	+$394K	0.12%	57
2023 Q1	–	Sell	-900	Closed	-$329K	–	362
2022 Q4	$329K	Sell	900 -1,100	-55%	-$390K	0.05%	170
2022 Q3	$647K	Buy	+2,000	New	+$634K	0.06%	163
2022 Q1	–	Sell	-3,460	Closed	-$956K	–	834
2021 Q4	$956K	Buy	3,460 +1,440	+71%	+$365K	0.07%	234
2021 Q3	$467K	Buy	+2,020	New	+$499K	0.05%	289
2021 Q1	–	Sell	-1,300	Closed	-$219K	–	883
2020 Q4	$219K	Buy	+1,300	New	+$194K	0.01%	419
2020 Q1	–	Sell	-32,544	Closed	-$4.28M	–	560
2019 Q4	$4.28M	Buy	+32,544	New	+$3.77M	0.28%	92
2019 Q2	–	Sell	-1,770	Closed	-$230K	–	419
2019 Q1	$230K	Buy	+1,770	New	+$215K	0.03%	202
2015 Q1	–	Sell	-5,489	Closed	-$379K	–	546
2014 Q4	$379K	Buy	+5,489	New	+$371K	0.02%	403

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bluefin Capital Management's LLY Position: Q2 2026 in Review

Bluefin Capital Management opened a new position in Eli Lilly (LLY) in Q2 2026: 386 shares worth $463K. The stake represents 0.12% of the portfolio and ranks #57 among its holdings. This is a return to the name: Bluefin Capital Management previously reported a position in LLY as recently as Q4 2022.

Bluefin Capital Management first reported a position in LLY in Q4 2014 and has held it in 9 quarters since. The position peaked at $4.28M in Q4 2019. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Bluefin Capital Management held 386 shares of Eli Lilly worth $463K as of Q2 2026.
Eli Lilly was a new Bluefin Capital Management position in Q2 2026.
Eli Lilly made up 0.12% of Bluefin Capital Management's portfolio in Q2 2026, its #57 holding.
Bluefin Capital Management first reported a position in Eli Lilly in Q4 2014 and has held it in 9 quarters since.
Bluefin Capital Management's Eli Lilly position peaked at $4.28M in Q4 2019.
4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bluefin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.